\-\ Texto\\:\\ \ \(0\)\
\-\ 3\\/5\\ left\\ lower\\ extremity\\ weakness\\.\ \(1\)\
\-\ diminished\\ proprioception\\.\ \(0\)\
\-\ loss\\ of\\ vision\\ in\\ left\\ eye\\.\ \(0\)\
\-\ supportive\ \(54\)\
\-\ non\\-contrast\\ ct\\ images\\ of\\ the\\ brain\\ demonstrate\\ a\\ 1\\.3\\ x\\ 1\\.2\\ cm\\ mass\\ within\\ the\\ left\\ optic\\ nerve\\ with\\ multiple\\ additional\\ diffuse\\ hemorrhagic\\ lesions\\ with\\ associated\\ vasogenic\\ edema\\ and\\ mass\\ effect\\.\\ \\ the\\ largest\\ and\\ most\\ concerning\\ mass\\ is\\ within\\ the\\ right\\ frontal\\ lobe\\.\\ \\ this\\ mass\\ measures\\ approximately\\ 2\\.9\\ cm\\ in\\ greatest\\ dimension\\.\ \(0\)\
\-\ a\\ whole\\ body\\ bone\\ scan\\ demonstrates\\ intense\\ focal\\ uptake\\ at\\ the\\ left\\ femoral\\ head\\,\\ and\\ subtle\\ intake\\ within\\ the\\ mid\\ right\\ femoral\\ diaphysis\\.\ \(0\)\
\-\ malignant\\ melanoma\ \(7\)\
\-\ metastatic\\ carcinoma\\ \\(breast\\,\\ kidney\\,\\ lung\\,\\ thyroid\\)\ \(0\)\
\-\ melanoma\\,\\ \ \(19\)\
\-\ lymphoma\ \(373\)\
\-\ sarcoma\ \(742\)\
\-\ the\\ patient\\ is\\ a\\ 79\\-year\\-old\\ woman\\ who\\ presented\\ with\\ a\\ two\\-day\\ history\\ of\\ left\\ lower\\ extremity\\ weakness\\ associated\\ with\\ loss\\ of\\ proprioception\\,\\ and\\ vomiting\\ after\\ falling\\ and\\ striking\\ the\\ back\\ of\\ her\\ head\\.\\ \\ the\\ patient\\'s\\ past\\ medical\\ history\\ is\\ significant\\ for\\ multiple\\ medical\\ problems\\,\\ including\\ recent\\ seizures\\.\ \(0\)\
\-\ radiologic\\ diagnosis\\:\\ patients\\ with\\ melanoma\\ of\\ 1\\ mm\\ thickness\\ will\\ undergo\\ chest\\ radiography\\.\\ \\ patients\\ with\\ advanced\\ disease\\ may\\ undergo\\ mr\\ imaging\\ of\\ the\\ head\\,\\ as\\ well\\ as\\ computed\\ tomography\\ of\\ the\\ chest\\,\\ abdomen\\,\\ and\\ pelvis\\.\ \(0\)\
\-\ however\\,\\ single\\ whole\\ body\\ positron\\ emission\\ tomography\\ is\\ quickly\\ emerging\\ as\\ the\\ study\\ of\\ choice\\ to\\ detect\\ metastatic\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ melanoma\\:\\ 0\\.24842238187068916\ \(0\)\
\-\ proprioception\\:\\ 0\\.22542146369508215\ \(0\)\
\-\ the\\:\\ 0\\.21232176949247858\ \(0\)\
\-\ whole\\:\\ 0\\.18613386072684293\ \(0\)\
\-\ tomography\\:\\ 0\\.17177615060301796\ \(0\)\
\-\ undergo\\:\\ 0\\.1656149212471261\ \(0\)\
\-\ head\\:\\ 0\\.15865961143615384\ \(0\)\
\-\ of\\:\\ 0\\.15617626008252716\ \(0\)\
\-\ left\\:\\ 0\\.15124150765678057\ \(0\)\
\-\ mass\\:\\ 0\\.1354829079917917\ \(0\)\
\-\ femoral\\:\\ 0\\.13181086958469768\ \(0\)\
\-\ emerging\\:\\ 0\\.13103265210290488\ \(0\)\
\-\ weakness\\:\\ 0\\.12943127386970474\ \(0\)\
\-\ extremity\\:\\ 0\\.12773312953193944\ \(0\)\
\-\ within\\:\\ 0\\.12252017778371113\ \(0\)\
\-\ positron\\:\\ 0\\.120257838941405\ \(0\)\
\-\ body\\:\\ 0\\.11671665539696986\ \(0\)\
\-\ emission\\:\\ 0\\.11271073184754107\ \(0\)\
\-\ medical\\:\\ 0\\.1127105044384671\ \(0\)\
\-\ and\\:\\ 0\\.10993916541635171\ \(0\)\
\-\ loss\\:\\ 0\\.10804570881940095\ \(0\)\
\-\ as\\:\\ 0\\.10686929911080956\ \(0\)\
\-\ striking\\:\\ 0\\.10525587884946279\ \(0\)\
\-\ quickly\\:\\ 0\\.10453273592860275\ \(0\)\
\-\ with\\:\\ 0\\.10417971690714116\ \(0\)\
\-\ cm\\:\\ 0\\.10185184404981211\ \(0\)\
\-\ patients\\:\\ 0\\.09976684803571484\ \(0\)\
\-\ metastatic\\:\\ 0\\.09726543279503025\ \(0\)\
\-\ is\\:\\ 0\\.09713483733499466\ \(0\)\
\-\ intake\\:\\ 0\\.09687730247639668\ \(0\)\
\-\ detect\\:\\ 0\\.09563305703428697\ \(0\)\
\-\ chest\\:\\ 0\\.09361222815164733\ \(0\)\
\-\ associated\\:\\ 0\\.09347466359521518\ \(0\)\
\-\ dimension\\:\\ 0\\.09146295519360466\ \(0\)\
\-\ lower\\:\\ 0\\.09062402154196546\ \(0\)\
\-\ radiography\\:\\ 0\\.09057444082464249\ \(0\)\
\-\ largest\\:\\ 0\\.09028920769325391\ \(0\)\
\-\ falling\\:\\ 0\\.09028920769325391\ \(0\)\
\-\ greatest\\:\\ 0\\.08867969170373324\ \(0\)\
\-\ diminished\\:\\ 0\\.0879333994569053\ \(0\)\
\-\ vasogenic\\:\\ 0\\.08722130077772802\ \(0\)\
\-\ multiple\\:\\ 0\\.08674380921770057\ \(0\)\
\-\ diaphysis\\:\\ 0\\.08631990222276956\ \(0\)\
\-\ computed\\:\\ 0\\.08546792081895312\ \(0\)\
\-\ concerning\\:\\ 0\\.08505882432691485\ \(0\)\
\-\ choice\\:\\ 0\\.08408084341162571\ \(0\)\
\-\ intense\\:\\ 0\\.083706252526463\ \(0\)\
\-\ advanced\\:\\ 0\\.08334047636765761\ \(0\)\
\-\ radiologic\\:\\ 0\\.08263377424104786\ \(0\)\
\-\ thickness\\:\\ 0\\.08229211720192157\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.07691757728919245\ \(0\)\
\-\ problems\\:\\ 0\\.07691757728919245\ \(0\)\
\-\ vision\\:\\ 0\\.07679845969854285\ \(0\)\
\-\ subtle\\:\\ 0\\.07644648761622813\ \(0\)\
\-\ optic\\:\\ 0\\.07633091258929364\ \(0\)\
\-\ disease\\:\\ 0\\.07444356843390551\ \(0\)\
\-\ sarcoma\\:\\ 0\\.07438528038035055\ \(0\)\
\-\ supportive\\:\\ 0\\.07408343071128719\ \(0\)\
\-\ seizures\\:\\ 0\\.07238595288653374\ \(0\)\
\-\ measures\\:\\ 0\\.07229687086901943\ \(0\)\
\-\ eye\\:\\ 0\\.07093689855925635\ \(0\)\
\-\ thyroid\\:\\ 0\\.06968639389841316\ \(0\)\
\-\ additional\\:\\ 0\\.06873958137025411\ \(0\)\
\-\ uptake\\:\\ 0\\.06818435200870131\ \(0\)\
\-\ single\\:\\ 0\\.06818435200870131\ \(0\)\
\-\ history\\:\\ 0\\.06775645498003692\ \(0\)\
\-\ vomiting\\:\\ 0\\.06561377952927852\ \(0\)\
\-\ breast\\:\\ 0\\.06439177585590053\ \(0\)\
\-\ mid\\:\\ 0\\.0638150066108617\ \(0\)\
\-\ including\\:\\ 0\\.06345880972798085\ \(0\)\
\-\ mm\\:\\ 0\\.06345880972798085\ \(0\)\
\-\ nerve\\:\\ 0\\.0632588742448929\ \(0\)\
\-\ malignant\\:\\ 0\\.06320928961109705\ \(0\)\
\-\ kidney\\:\\ 0\\.06229604211119774\ \(0\)\
\-\ effect\\:\\ 0\\.06220295938087929\ \(0\)\
\-\ pelvis\\:\\ 0\\.0620184495646347\ \(0\)\
\-\ recent\\:\\ 0\\.06004048293006612\ \(0\)\
\-\ back\\:\\ 0\\.05913851570910497\ \(0\)\
\-\ study\\:\\ 0\\.05913851570910497\ \(0\)\
\-\ right\\:\\ 0\\.05879755097640446\ \(0\)\
\-\ past\\:\\ 0\\.05771941162328915\ \(0\)\
\-\ patient\\:\\ 0\\.05768176469830705\ \(0\)\
\-\ mr\\:\\ 0\\.057375486764549156\ \(0\)\
\-\ frontal\\:\\ 0\\.05707232888849872\ \(0\)\
\-\ will\\:\\ 0\\.05707232888849872\ \(0\)\
\-\ approximately\\:\\ 0\\.056579845159342335\ \(0\)\
\-\ diffuse\\:\\ 0\\.055608959972405614\ \(0\)\
\-\ her\\:\\ 0\\.055397873534651754\ \(0\)\
\-\ brain\\:\\ 0\\.055278527309146556\ \(0\)\
\-\ abdomen\\:\\ 0\\.05410532022387398\ \(0\)\
\-\ lung\\:\\ 0\\.05394082377335248\ \(0\)\
\-\ focal\\:\\ 0\\.053040193449361804\ \(0\)\
\-\ carcinoma\\:\\ 0\\.053040193449361804\ \(0\)\
\-\ edema\\:\\ 0\\.05288653714538461\ \(0\)\
\-\ lymphoma\\:\\ 0\\.05281027483617925\ \(0\)\
\-\ scan\\:\\ 0\\.05260871908515905\ \(0\)\
\-\ however\\:\\ 0\\.05248406108339301\ \(0\)\
\-\ presented\\:\\ 0\\.051709083435440194\ \(0\)\
\-\ lobe\\:\\ 0\\.05124363640313481\ \(0\)\
\-\ significant\\:\\ 0\\.05119784912551034\ \(0\)\
\-\ lesions\\:\\ 0\\.050925922024906055\ \(0\)\
\-\ who\\:\\ 0\\.050158934983994055\ \(0\)\
\-\ bone\\:\\ 0\\.0483827641925621\ \(0\)\
\-\ imaging\\:\\ 0\\.04660067360304926\ \(0\)\
\-\ woman\\:\\ 0\\.046181199431638814\ \(0\)\
\-\ most\\:\\ 0\\.04614812544147118\ \(0\)\
\-\ demonstrate\\:\\ 0\\.04609864602723524\ \(0\)\
\-\ diagnosis\\:\\ 0\\.04596746575917128\ \(0\)\
\-\ may\\:\\ 0\\.044623060373151856\ \(0\)\
\-\ demonstrates\\:\\ 0\\.04454836167335546\ \(0\)\
\-\ in\\:\\ 0\\.044117939800283244\ \(0\)\
\-\ after\\:\\ 0\\.0430167362524765\ \(0\)\
\-\ well\\:\\ 0\\.042935914045199454\ \(0\)\
\-\ images\\:\\ 0\\.041017175907868936\ \(0\)\
\-\ ct\\:\\ 0\\.03375865175027985\ \(0\)\
\-\ at\\:\\ 0\\.03349292272372683\ \(0\)\
\-\ this\\:\\ 0\\.03046964699605488\ \(0\)\
\-\ for\\:\\ 0\\.026876112225186658\ \(0\)\
\-\ to\\:\\ 0\\.02216808114964852\ \(0\)\
